Given the association between metabolic syndrome traits and colorectal cancer risk and the key role of ADIPOQ and its receptor genes in the development of obesity and insulin resistance, emerging interest was focused on the role of ADIPOQ and its receptor genes in colorectal carcinogenesis. The gene discussed is ADIPOQ; the disease is obesity disorder.